Follow
Scott Ayton, PhD
Scott Ayton, PhD
Florey Institute of Neuroscience and Mental Health
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
P Lei, S Ayton, DI Finkelstein, L Spoerri, GD Ciccotosto, DK Wright, ...
Nature medicine 18 (2), 291-295, 2012
6172012
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
QZ Tuo, P Lei, KA Jackman, XL Li, H Xiong, ZY Liuyang, L Roisman, ...
Molecular psychiatry 22 (11), 1520-1530, 2017
5132017
Current state of Alzheimer’s fluid biomarkers
JL Molinuevo, S Ayton, R Batrla, MM Bednar, T Bittner, J Cummings, ...
Acta neuropathologica 136, 821-853, 2018
4872018
Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases
D Furtado, M Björnmalm, S Ayton, AI Bush, K Kempe, F Caruso
Advanced materials 30 (46), 1801362, 2018
4822018
A delicate balance: Iron metabolism and diseases of the brain
D Hare, S Ayton, A Bush, P Lei
Frontiers in aging neuroscience 5, 34, 2013
4092013
Metallostasis in Alzheimer's disease
S Ayton, P Lei, AI Bush
Free Radical Biology and Medicine 62, 76-89, 2013
3762013
Ferroptosis and cell death mechanisms in Parkinson's disease
SJ Guiney, PA Adlard, AI Bush, DI Finkelstein, S Ayton
Neurochemistry international 104, 34-48, 2017
3072017
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
2872015
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
S Ayton, P Lei, JA Duce, BXW Wong, A Sedjahtera, PA Adlard, AI Bush, ...
Annals of neurology 73 (4), 554-559, 2013
2682013
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
L Mahoney-Sánchez, H Bouchaoui, S Ayton, D Devos, JA Duce, ...
Progress in neurobiology 196, 101890, 2021
2642021
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
S Ayton, Y Wang, I Diouf, JA Schneider, J Brockman, MC Morris, AI Bush
Molecular psychiatry 25 (11), 2932-2941, 2020
2452020
Tau protein: relevance to Parkinson's disease
P Lei, S Ayton, DI Finkelstein, PA Adlard, CL Masters, AI Bush
The international journal of biochemistry & cell biology 42 (11), 1775-1778, 2010
2432010
Iron and Alzheimer’s disease: an update on emerging mechanisms
DJR Lane, S Ayton, AI Bush
Journal of Alzheimer's Disease 64 (s1), S379-S395, 2018
2372018
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ...
Brain 140 (8), 2112-2119, 2017
2342017
The essential elements of Alzheimer’s disease
P Lei, S Ayton, AI Bush
Journal of Biological Chemistry 296, 2021
1992021
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
LW Hung, VL Villemagne, L Cheng, NA Sherratt, S Ayton, AR White, ...
Journal of Experimental Medicine 209 (4), 837-854, 2012
1812012
GSK-3 in neurodegenerative diseases
P Lei, S Ayton, AI Bush, PA Adlard
International journal of Alzheimer’s disease 2011, 2011
1782011
Nigral iron elevation is an invariable feature of Parkinson’s disease and is a sufficient cause of neurodegeneration
S Ayton, P Lei
BioMed research international 2014, 2014
1562014
Motor and cognitive deficits in aged tau knockout mice in two background strains
P Lei, S Ayton, S Moon, Q Zhang, I Volitakis, DI Finkelstein, AI Bush
Molecular neurodegeneration 9, 1-12, 2014
1472014
Biometals and their therapeutic implications in Alzheimer's disease
S Ayton, P Lei, AI Bush
Neurotherapeutics 12 (1), 109-120, 2015
1342015
The system can't perform the operation now. Try again later.
Articles 1–20